Niyyar Vandana Dua
Division of Nephrology, Emory University, Atlanta, Georgia 30322, USA.
Semin Dial. 2012 Nov-Dec;25(6):693-9. doi: 10.1111/j.1525-139X.2011.00991.x. Epub 2011 Dec 16.
Vascular access dysfunction is a major cause of morbidity in hemodialysis (HD) patients. An upper extremity autogenous arteriovenous fistula (AVF) that preferentially involves the cephalic vein is the access of choice for HD patients, followed by autogenous AVF utilizing the basilic vein and the use of prosthetic arteriovenous grafts (AVGs). Despite these recommendations, central venous catheter (CVC) use is widespread among both incident and prevalent HD patients. Long-term use of CVCs for HD is complicated by a high rate of infection and thrombus-related dysfunction. Catheter locking solutions have been used both prophylactically and therapeutically for catheter thrombosis as well as catheter-related infections, with varying degrees of success. This review aims to address the different catheter locking solutions, their advantages and disadvantages, and new directions in this field.
血管通路功能障碍是血液透析(HD)患者发病的主要原因。优先累及头静脉的上肢自体动静脉内瘘(AVF)是HD患者的首选血管通路,其次是利用贵要静脉的自体AVF和使用人工动静脉移植物(AVG)。尽管有这些建议,但中心静脉导管(CVC)在初治和长期HD患者中仍广泛使用。HD长期使用CVC会因感染率高和血栓相关功能障碍而变得复杂。导管封管溶液已被预防性和治疗性地用于导管血栓形成以及导管相关感染,取得了不同程度的成功。本综述旨在探讨不同的导管封管溶液、它们的优缺点以及该领域的新方向。